​

Vir Bio (VIR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Vir Bio Revenue Highlights

Latest Revenue (Y)

$68.56M

Latest Revenue (Q)

$-29.00K

Main Segment (Y)

License And Collaboration Revenue

Main Geography (Y)

Non-US

Vir Bio Revenue by Period

Vir Bio Revenue by Year

DateRevenueChange
2025-12-31$68.56M-7.61%
2024-12-31$74.20M-13.90%
2023-12-31$86.18M-94.67%
2022-12-31$1.62B47.51%
2021-12-31$1.10B1528.99%
2020-12-31$67.25M9357.81%
2019-12-31$711.00K-18.09%
2018-12-31$868.00K482.55%
2017-12-31$149.00K-

Vir Bio generated $68.56M in revenue during NA 2025, up -7.61% compared to the previous quarter, and up 101.95% compared to the same period a year ago.

Vir Bio Revenue by Quarter

DateRevenueChange
2026-03-31$-29.00K-100.05%
2025-12-31$64.07M26595.83%
2025-09-30$240.00K-80.23%
2025-06-30$1.21M-59.96%
2025-03-31$3.03M-75.50%
2024-12-31$12.37M419.92%
2024-09-30$2.38M-22.60%
2024-06-30$3.08M-94.55%
2024-03-31$56.38M235.83%
2023-12-31$16.79M536.11%
2023-09-30$2.64M-30.50%
2023-06-30$3.80M-93.97%
2023-03-31$62.96M27.42%
2022-12-31$49.41M-86.81%
2022-09-30$374.56M-1021.90%
2022-06-30$-40.63M-103.30%
2022-03-31$1.23B51.64%
2021-12-31$812.75M684.38%
2021-09-30$103.62M-41.48%
2021-06-30$177.07M29167.44%
2021-03-31$605.00K101.00%
2020-12-31$301.00K60.11%
2020-09-30$188.00K-99.72%
2020-06-30$66.27M1058.95%
2020-03-31$5.72M483.47%
2019-12-31$980.00K313.50%
2019-09-30$237.00K175.58%
2019-06-30$86.00K405.88%
2019-03-31$17.00K183.33%
2018-12-31$6.00K-94.74%
2018-09-30$114.00K-95.10%
2018-06-30$2.33M-
2018-03-31$2.33M-

Vir Bio generated $-29.00K in revenue during Q1 2026, up -100.05% compared to the previous quarter, and up -0.23% compared to the same period a year ago.

Vir Bio Revenue Breakdown

Vir Bio Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22Dec 21
Other Revenue$3.39M----
Grant$2.04M$10.49M$46.69M--
License And Collaboration Revenue$63.13M----
Collaboration Revenue-$8.38M$37.27M$1.51B$917.19M
Contract Revenue-$55.33M$2.23M$52.71M$169.87M
License Revenue-----
License---$22.29M-

Vir Bio's latest annual revenue breakdown by segment (product or service), as of Dec 25: License And Collaboration Revenue (92.09%), Other Revenue (4.94%), and Grant (2.97%).

Quarterly Revenue by Product

Product/ServiceMar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
License And Collaboration Revenue$-41.00K-------------------
Grant$12.00K$310.00K$305.00K$183.00K$1.24M$1.10M$2.09M$2.13M$5.17M$23.43M$6.74M$16.52M--------
Collaboration Revenue--$-65.00K$-495.00K$-70.00K$8.32M$55.00K-$-4.39M$46.57M$21.61M$309.14M$-54.94M$1.23B$809.46M$102.40M$5.33M---
Contract Revenue---$1.53M$1.86M$865.00K$1.39M$886.00K$52.19M$744.00K$289.00K$1.06M$138.00K$180.00K$40.00M$12.25M$282.00K$293.00K$315.00K-
License Revenue--------------------
License--------------$22.29M-----

Vir Bio's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Grant (-41.38%), and License And Collaboration Revenue (141.38%).

Vir Bio Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25Dec 24
UNITED STATES$2.04M$11.53M
Non-US$64.27M$60.31M

Vir Bio's latest annual revenue breakdown by geography, as of Dec 25: Non-US (96.93%), and UNITED STATES (3.07%).

Quarterly Revenue by Country

CountryMar 26Dec 25Sep 25Jun 25Mar 25
UNITED STATES$12.00K$310.00K$305.00K$183.00K$1.24M
Non-US$-41.00K$60.94M$-65.00K$1.53M$1.86M

Vir Bio's latest quarterly revenue breakdown by geography, as of Mar 26: UNITED STATES (-41.38%), and Non-US (141.38%).

Vir Bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IOVAIovance Biotherapeutics$263.50M$71.43M
GERNGeron$183.88M$47.23M
DNAGinkgo Bioworks$170.16M-
DAWNDay One Biopharmaceuticals$158.18M$39.80M
VIRVir Bio$68.56M$-29.00K
KURAKura Oncology$67.48M$18.27M
MRVIMaravai LifeSciences$49.87M$65.84M
LENZLENZ Therapeutics$19.09M$1.90M
PRMEPrime Medicine$4.63M-
YDESYD Bio Limited Ordinary Shares$510.36K-
REPLReplimune Group--

VIR Revenue FAQ

What is Vir Bio’s yearly revenue?

Vir Bio's yearly revenue for 2025 was $68.56M, representing a decrease of -7.61% compared to 2024. The company's yearly revenue for 2024 was $74.2M, representing a decrease of -13.90% compared to 2023. VIR's yearly revenue for 2023 was $86.18M, representing a decrease of -94.67% compared to 2022.

What is Vir Bio’s quarterly revenue?

Vir Bio's quarterly revenue for Q1 2026 was $-29K, a -100.05% decrease from the previous quarter (Q4 2025), and a -100.96% decrease year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $64.07M, a 26595.83% increase from the previous quarter (Q3 2025), and a 417.78% increase year-over-year (Q4 2024). VIR's quarterly revenue for Q3 2025 was $240K, a -80.23% decrease from the previous quarter (Q2 2025), and a -89.92% decrease year-over-year (Q3 2024).

What is Vir Bio’s revenue growth rate?

Vir Bio's revenue growth rate for the last 3 years (2023-2025) was -20.45%, and for the last 5 years (2021-2025) was -93.74%.

What are Vir Bio’s revenue streams?

Vir Bio's revenue streams in c 25 are Other Revenue, Grant, and License And Collaboration Revenue. Other Revenue generated $3.39M in revenue, accounting 4.94% of the company's total revenue Grant generated $2.04M in revenue, accounting 2.97% of the company's total revenue, down -80.60% year-over-year. License And Collaboration Revenue generated $63.13M in revenue, accounting 92.09% of the company's total revenue

What is Vir Bio’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Vir Bio was License And Collaboration Revenue. This segment made a revenue of $63.13M, representing 92.09% of the company's total revenue.